FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Development Technologies Corp. Stock AnalysisComprehensive stock analysis for Development Technologies Corp. (DVTC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisDVTC
DVTC
Development Technologies Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
DVTC
Home🔹Stocks🔹Development Technologies Corp.

Development Technologies Corp.

🇺🇸DVTC•OTC

Development Technologies Corp.

🇺🇸DVTC•OTC
Market cap
$272.50M
Sentiment

Your view on DVTC

Mkt Cap
$272.50M
Sentiment
Your view
DVTC
Development Technologies Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
DVTC
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Development Technologies Corp.

Industry
Shell Companies
Sector
Financial Services
CEO
Daniel Kesonen
Headquarters
4440 PGA Boulevard, Palm Beach Gardens, FL, US
Industry
Shell Companies
Sector
Financial Services
CEO
Daniel Kesonen
Headquarters
4440 PGA Boulevard, Palm Beach Gardens, FL, US
Description

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases.

It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Development Technologies Corp., and the rating behind it. DVTC last traded at $5.00; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Development Technologies Corp.. Starting points for Development Technologies Corp.: beta 3.93 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Development Technologies Corp.. Development Technologies Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Development Technologies Corp.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Development Technologies Corp.. Development Technologies Corp. has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Development Technologies Corp. valued side by side against its closest peers. Development Technologies Corp. is measured against Shell Companies peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Development Technologies Corp., and how their positions are changing. At a $272.5M market value, institutional positions materially move Development Technologies Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Development Technologies Corp. executives and directors. Shares of Development Technologies Corp. have traded between $2.02 and $20.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Development Technologies Corp.. Development Technologies Corp. is a $272.5M Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Development Technologies Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Development Technologies Corp.. Coverage tracks Development Technologies Corp. within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Peer companies

  • CNCN — Chun Can Capital Group

More Shell Companies companies

  • AMLH — American Leisure Holdings, Inc.
  • ANAS — Alternaturals, Inc.
  • AOGO — Arogo Capital Acquisition Corp.
  • AOGOU — Arogo Capital Acquisition Corp.
  • APAC — StoneBridge Acquisition II Corporation
  • APACU — StoneBridge Acquisition II Corporation
  • APMC — Ampercap Acquisition Co.
  • APMCR — AmperCap Acquisition Company
  • APMCU — AmperCap Acquisition Company
  • APSI — Aqua Power Systems Inc.
  • APUR — Aperture AC Class A Ordinary Shares
  • APURR — Aperture AC

News

Latest Market News